VIKING GLOBAL INVESTORS LP - Q3 2023 holdings

$24.6 Billion is the total value of VIKING GLOBAL INVESTORS LP's 80 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 48.4% .

 Value Shares↓ Weighting
WDAY BuyWORKDAY INCcl a$1,125,092,963
+63.9%
5,236,644
+72.3%
4.57%
+62.5%
AMZN BuyAMAZON COM INC$1,112,299,110
+93.9%
8,749,993
+98.8%
4.51%
+92.2%
UPS BuyUNITED PARCEL SERVICE INCcl b$1,038,169,641
+551.4%
6,660,484
+649.1%
4.21%
+545.2%
MSFT BuyMICROSOFT CORP$954,953,984
+133.3%
3,024,399
+151.6%
3.88%
+131.2%
UNH BuyUNITEDHEALTH GROUP INC$936,756,785
+8.6%
1,857,944
+3.5%
3.80%
+7.6%
FB BuyMETA PLATFORMS INCcl a$917,748,575
+23.3%
3,057,022
+17.8%
3.72%
+22.2%
BuyGENERAL ELECTRIC CO$884,057,958
+12.7%
7,996,906
+12.0%
3.59%
+11.8%
MCK BuyMCKESSON CORP$633,891,716
+183.0%
1,457,725
+178.1%
2.57%
+180.5%
HDB BuyHDFC BANK LTDsponsored ads$596,946,517
-8.0%
10,116,023
+8.6%
2.42%
-8.8%
AMP BuyAMERIPRISE FINL INC$571,671,054
+53.1%
1,734,018
+54.3%
2.32%
+51.7%
SQ NewBLOCK INCcl a$545,496,00212,324,808
+100.0%
2.21%
PPG BuyPPG INDS INC$524,942,871
+293.3%
4,044,244
+349.4%
2.13%
+290.1%
TMO BuyTHERMO FISHER SCIENTIFIC INC$455,408,742
+4.8%
899,715
+8.0%
1.85%
+3.8%
DASH BuyDOORDASH INCcl a$426,556,973
+106.7%
5,367,522
+98.8%
1.73%
+104.9%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$372,983,547
+3.5%
4,215,456
+1.4%
1.51%
+2.6%
FCX NewFREEPORT-MCMORAN INCcl b$364,311,3309,769,679
+100.0%
1.48%
VVV BuyVALVOLINE INC$285,877,335
-0.8%
8,867,163
+15.4%
1.16%
-1.7%
EPAM BuyEPAM SYS INC$234,850,498
+36.6%
918,497
+20.1%
0.95%
+35.4%
FIVN BuyFIVE9 INC$231,077,804
+29.2%
3,593,745
+65.6%
0.94%
+28.1%
AJG BuyGALLAGHER ARTHUR J & CO$218,315,913
+20.9%
957,820
+16.5%
0.89%
+19.9%
KRTX BuyKARUNA THERAPEUTICS INC$191,285,261
-6.9%
1,131,263
+19.3%
0.78%
-7.8%
ISRG NewINTUITIVE SURGICAL INC$187,352,921640,983
+100.0%
0.76%
MET NewMETLIFE INC$184,537,4262,933,356
+100.0%
0.75%
PGR BuyPROGRESSIVE CORP$159,543,355
+204.0%
1,145,322
+188.9%
0.65%
+200.9%
NewRAYZEBIO INC$147,467,9406,642,700
+100.0%
0.60%
INBX BuyINHIBRX INC$131,217,657
-23.9%
7,150,826
+7.7%
0.53%
-24.6%
CL BuyCOLGATE PALMOLIVE CO$101,320,728
+6.2%
1,424,845
+15.0%
0.41%
+5.1%
KBR BuyKBR INC$91,664,018
+17.1%
1,555,209
+29.3%
0.37%
+16.2%
CNHI BuyCNH INDL N V$81,569,500
+18.8%
6,741,281
+41.4%
0.33%
+17.8%
DOV NewDOVER CORP$74,859,252536,587
+100.0%
0.30%
BuyNEWAMSTERDAM PHARMA COMPANYordinary shares$74,227,226
-4.3%
8,024,565
+23.0%
0.30%
-5.3%
KDP NewKEURIG DR PEPPER INC$72,240,4002,288,261
+100.0%
0.29%
BEKE NewKE HLDGS INCsponsored ads$71,702,4004,620,000
+100.0%
0.29%
THC BuyTENET HEALTHCARE CORP$67,592,598
+128.3%
1,025,840
+182.0%
0.27%
+126.4%
ZI BuyZOOMINFO TECHNOLOGIES INC$61,568,749
+96.4%
3,754,192
+204.1%
0.25%
+95.3%
BSX NewBOSTON SCIENTIFIC CORP$58,623,4181,110,292
+100.0%
0.24%
CFLT NewCONFLUENT INC$58,718,5841,983,066
+100.0%
0.24%
VKTX BuyVIKING THERAPEUTICS INC$50,626,608
-11.9%
4,573,316
+29.0%
0.20%
-12.8%
NewMOBILEYE GLOBAL INC$42,035,8031,011,692
+100.0%
0.17%
DG NewDOLLAR GEN CORP NEW$38,952,598368,172
+100.0%
0.16%
FL NewFOOT LOCKER INC$38,785,1622,235,456
+100.0%
0.16%
EWTX BuyEDGEWISE THERAPEUTICS INC$35,291,907
-23.4%
6,159,146
+3.6%
0.14%
-24.3%
NewARM HOLDINGS PLCsponsored adr$32,112,000600,000
+100.0%
0.13%
FTCH BuyFARFETCH LTDord sh cl a$22,663,979
-21.3%
10,844,009
+127.4%
0.09%
-22.0%
BuyVERASTEM INC$19,969,654
+42.3%
2,456,292
+30.2%
0.08%
+42.1%
NewMAPLEBEAR INC$3,711,250125,000
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC36Q3 20237.0%
AMAZON COM INC34Q3 202310.6%
META PLATFORMS INC34Q3 202310.4%
MICROSOFT CORP30Q3 20239.1%
THERMO FISHER SCIENTIFIC INC29Q3 20235.4%
NETFLIX INC26Q2 20236.0%
MASTERCARD INCORPORATED25Q3 20233.9%
ELEVANCE HEALTH INC24Q2 202310.2%
ALPHABET INC22Q2 20219.3%
UNITEDHEALTH GROUP INC22Q3 20235.3%

View VIKING GLOBAL INVESTORS LP's complete holdings history.

Latest significant ownerships (13-D/G)
VIKING GLOBAL INVESTORS LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Celldex Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Coupa Software IncSold outFebruary 14, 202300.0%
FIGS, Inc.Sold outFebruary 14, 202300.0%
Guardant Health, Inc.February 14, 20234,107,6444.0%
Orion Acquisition Corp.Sold outFebruary 14, 202300.0%
PROCEPT BioRobotics CorpSold outFebruary 14, 202300.0%
Frazier Lifesciences Acquisition CorpSold outNovember 25, 202200.0%
Cazoo Group LtdNovember 10, 202260,000,0007.3%
AbCellera Biologics Inc.Sold outFebruary 14, 202200.0%
Athira Pharma, Inc.Sold outFebruary 14, 202200.0%

View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.

Latest filings
TypeFiled
32024-03-20
SC 13G/A2024-03-20
42024-03-07
42024-03-07
42024-03-01
42024-03-01
SC 13G/A2024-03-01
42024-02-28
42024-02-28
SC 13G/A2024-02-28

View VIKING GLOBAL INVESTORS LP's complete filings history.

Compare quarters

Export VIKING GLOBAL INVESTORS LP's holdings